Indivior PLC (INDV)
NASDAQ: INDV · IEX Real-Time Price · USD
10.41
-0.05 (-0.48%)
At close: Jul 19, 2024, 4:00 PM
10.27
-0.14 (-1.34%)
Pre-market: Jul 22, 2024, 7:31 AM EDT

Indivior Revenue

Indivior had revenue of $1.12B in the twelve months ending March 31, 2024, with 18.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $284.00M with 12.25% year-over-year growth. In the year 2023, Indivior had annual revenue of $1.09B with 21.31% growth.

Revenue (ttm)
$1.12B
Revenue Growth
+18.57%
P/S Ratio
1.28
Revenue / Employee
$965,636
Employees
1,164
Market Cap
1.44B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.09B192.00M21.31%
Dec 31, 2022901.00M110.00M13.91%
Dec 31, 2021791.00M144.00M22.26%
Dec 31, 2020647.00M-367.00M-36.19%
Dec 31, 20151.01B-101.00M-9.06%
Dec 31, 20141.12B-101.00M-8.31%
Dec 31, 20131.22B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.25B
Brookdale Senior Living 3.05B
Tilray Brands 743.25M
U.S. Physical Therapy 611.97M
InMode 466.26M
BioCryst Pharmaceuticals 355.40M
Vir Biotechnology 79.60M
Spyre Therapeutics 688.00K
Revenue Rankings